| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |